Summary
In a double-blind placebo-controlled study, the encephalotropic, psychotropic, pharmacodynamic and pharmacokinetic properties of 2 new substances, clovoxamine (a 5-HT and NE re-uptake inhibitor) and fluvoxamine (a selective 5-HT inhibitor) were investigated utilizing quantitative pharmaco-EEG, psychometric and blood level analyses. Ten normal volunteers received randomized and in weekly intervals oral single doses 50 mg, 75 mg and 125 mg clovoxamine, 75 mg fluvoxamine, placebo and as reference drug 75 mg imipramine. Quantitative EEG, psychometric data, pulse, blood pressure, side effects and pharmacokinetic data were studied at the hours 0, 2, 4, 6 and 8. Plasma levels of both substances peaked in the 4th to 6th hour and declined slowly thereafter. Digital computer period analysis of the EEG demonstrated after clovoxamine only minor changes characterized by an increase of fast beta-activities suggesting slight activating qualities of the drug. On the other hand 75 mg fluvoxamine and especially 75 mg imipramine produced marked CNS changes characterized by a concomitant increase of slow and fast activities and a decrease of alpha-activity. However, 75 mg fluvoxamine induced less augmentation of slow activity than imipramine indicating less sedative properties of fluvoxamine than the standard reference drug. Psychometric tests demonstrated after 50 and 75 mg clovoxamine and 75 mg fluvoxamine an increase in attention, attention variability, concentration, CFF and after-effect in the Archimedean Spiral (indicating central activation), further an improvement in mood and affectivity as compared with placebo, while 125 mg clovoxamine and 75 mg imipramine produced an increase in reaction time, deterioration of mood and affect and psychomotor activity. The latter changes were observed also after other antidepressants in normals. Pharmacodynamic investigations regarding dose-efficacy and time-efficacy relations based on both EEG and psychometric parameters revealed that 75 mg imipramine was the most effective compound, followed by 75 mg fluvoxamine and 125 mg, 75 mg and 50 mg clovoxamine. The peak effect of clovoxamine and fluvoxamine was observed around the 6th hour, while 75 mg imipramine was maximally effective between the 2nd and the 4th hours. Side effects were minimal after clovoxamine (interestingly euphoria in 3 subjects), while tiredness was seen in 5 out of 10 subjects after 75 mg fluvoxamine and in 8 out of 10 subjects after 75 mg imipramine. There were no clinically relevant changes in pulse, systolic and diastolic blood pressure.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Burch, N. R., Nettleton, W. H., Sweeney, J., Edward, R. J. Period analysis of electroencephalogram on a general purpose digital computer. Ann. N.Y. Acad. Sci.115, 827–943 (1964).
De Bree, H.: Gas Chromatographic determination of fluvoxamine maleate (DU 23000) in plasma. Unpublished Report no. 56630/23 Philips-Duphar B.V. (1976 a).
De Bree, H.: Gas chromatographic determination of clovoxamine fumarate (DU 23811) in plasma. Unpublished Report no. 56630/30 Philips-Duphar B.V. (1976 b).
De Bree, H., Van der Schoot, J. B.: Plasma levels of fluvoxamine after oral administration of 100 mg of fluvoxamine maleate to ten healthy volunteers. Unpublished Report no. 56654/22 Philips-Duphar B.V. (1976 a).
De Bree, H., Van der Schoot, J. B.: Plasma levels of clovoxamine after oral administration of 60 mg of clovoxamine fumarate to six healthy volunteers. Unpublished Report no. 56654/23 Philips-Duphar B.V. (1976 b).
Duphar-Philips B.V.: A summary of the biological properties of fluvoxamine maleate (DU 23000). Unpublished Report no. 56638/25M (1979 a).
Duphar-Philips B.V.: A summary of the biological properties of clovoxamine fumarate (DU 23811). Unpublished Report no. 56638/24M (1979 b).
Fink, M. Cerebral electrometry-quantitative EEG applied to human psychopharmacology. In: Computerized EEG Analysis (Dolce, G., Künkel, H., eds.), pp. 271–288. Stuttgart: Fischer. 1975.
Galeazzi, R. L., Benet, L. Z., Sheiner, L. B. Relationship between the pharmacokinetics and pharmacodynamics of procainamide. Clin. Pharmacol. Ther.20, 278–289 (1976).
Grünberger, J. Psychodiagnostik des Alkoholkranken. Methodischer Beitrag zur Bestimmung der Organizität in der Psychiatrie. Wien: Maudrich. 1977.
Itil, T. M. Quantitative pharmaco-electroencephalography. In: Psychotropic drugs and the human EEG (Itil, T. M., ed.), pp. 43–75. Basel: Karger. 1974.
Itil, T. M.: Computerized electroencephalographic (C.E.E.G.) studies of clovoxamine. Unpublished Report to Philips-Duphar (1979).
Itil, T. M., Bhattachyaryya, A., Polvan, N., Huque, M., Menon, G. N. Fluvoxamine (DU 23000), a new antidepressant. Quantitative pharmaco-electroencephalography and pilot clinical trials. Prog. Neuro-Psychopharmac.1, 309–322 (1977).
Osgood, C. E., Suci, G. J., Tannenbaum, P. H. The measurement of meaning. Urbana: University Press. 1975.
Saletu, B. Psychopharmaka, Gehirntätigkeit und Schlaf. Basel: Karger. 1977.
Saletu, B., Schjerve, M., Grünberger, J., Schanda, H., Arnold, O. H. Fluvoxamine—A new serotonin re-uptake inhibitor: first clinical and psychometric experiences in depressed patients. J. Neural Transm.41, 17–36 (1977).
Saletu, B., Grünberger, J., Linzmayer, L., Anderer, P. Classification and assessment of pharmacodynamics of SGD-SCHA 1059 (Binodaline) by quantitative EEG and psychometric analyses. In: Advances in Biological Psychiatry (Perris, C., ed.), Vol. 4. Basel: Karger. 1980.
Saletu, B., Taeuber, K. Serum levels of nomifensine and pharmacodynamics assessed by the computer-pharmaco-EEG. In: Nomifensine (Stonier, P. D., Jenner, F. A., eds.), International Congress and Symposium Series, No. 25, pp. 32–38. London: Academic Press Inc. and The Royal Society of Medicine. 1980.
Zerssen, V. C., Koeller, D. M., Rey, E. R. Die Befindlichkeitsskala (B-S)-ein einfaches Instrument zur Objektivierung von Befindlichkeitsstörungen, insbesondere im Rahmen von Längsschnittuntersuchungen. Arzneim.-Forsch.20, 915–918 (1970).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Saletu, B., Grünberger, J., Rajna, P. et al. Clovoxamine and fluvoxamine-2 biogenic amine re-uptake inhibiting antidepressants: Quantitative EEG, psychometric and pharmacokinetic studies in man. J. Neural Transmission 49, 63–86 (1980). https://doi.org/10.1007/BF01249190
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01249190